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Results:
 
  Serum troponin was elevated in 23 patients (15,7%). 
After multivariate analysis, 6 independent factors were associated with
troponin elevation : diabetes, 2 or more prior cardiovascular events, thrombol-
ysis, multiple localization of stroke, SGOT elevation and creatinin> 120 µmol/
L. Moreover, the 3 factors associated with in-hospital mortality after logistic
regression were troponin elevation (OR=2,56 [1,11-6,02] p=0,031), prior myo-
cardial infarction (OR=2,94 [1,16-7,95] p=0,002) and severe NIHSS at admis-
sion (OR=3,07 [1,35-7,39] p=0,007) 
Only 2 cardiac MRI have been readable because other patients were died
before the exam or were unable to have this exam because of stroke severity,
confusion or rapid atrial fibrillation. One of these patients had an acute myo-
cardial infarction diagnosed by cardiac MRI but a normal coronarography. 
 
Conclusion:
 
 Elevated troponin in acute ischaemic stroke is an independent
factor of in-hospital mortality. A troponin rise is more frequent in patients with
diabetes or prior cardiovascular events that’s why a screening of ischaemic heart
disease should be performed. Cardiac MRI can’t be widely performed at the early
stage of stroke, however it has been decisive for one patient in this study.
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Background:
 
 In the new (2007) universal definition for myocardial infarc-
tion (MI), the type-5 corresponded to MI after coronary revascularization, with
cardiac enzymes release >5x normal values (N) required after coronary artery
bypass graft (CABG) surgery. However, data on long-term prognosis of
patients with post-operative troponin release are scarce. 
 
Methods:
 
 We followed up 826 consecutive patients operated for CABG
between 1998 and 2002 in our institution. Post-operative troponin Ic (Tr-Ic)
release has been systematically monitored. The primary outcome was total
mortality. The secondary outcome was composite and combined: death, acute
coronary syndrome, stroke, coronary or peripheral revascularization. 
 
Results: 
 
Among the 693 men and 133 women (age 66.1 ± 9.3 yrs), post-
operative Tr-Ic peak >5xN, >10xN and >20xN were at 54.8%, 29.6% and
15.6%, respectively. During the follow-up period (6.5 ± 2.7 yrs), 146 (17.6%)
deceased, and 302 (36.6%) met the composite outcome. Only the survival
curves of those with Tr-Ic peak >10xN were significantly poorer than those
without type-5 MI (Figure). Adjusted for age, sex, use of beta-blockers and
statins, CVD risk factors, NYHA stage, LVEF <40%, number of bypasses, on/
off-pump surgery, atrial fibrillation, peripheral artery or chronic kidney dis-
ease, only Tr-Ic >20xN was associated with mortality, and Tr-Ic >10xN was
predictive for the composite outcome (table). 
 
Conclusions:
 
 This series with the longest follow-up ever published con-
firms the prognostic value of troponin release after CABG. However, the cur-
rent type-5 MI definition after CABG is not specific enough to stratify the
long-term post-operative prognosis. Higher thresholds are mandatory. 
 
(Voir tableau ci-dessous)
 
328
 
Microvascular obstruction assessed by 3-tesla magnetic resonance
imaging in acute myocardial infarction is correlated with plasma tro-
ponin I levels
 
Nicolas Meneveau (1), Romain Chopard (1), Marie France Séronde (1),
Vincent Descotes-Genon (1), Jerome Jehl (2), Alexandre Comte (2), Fran-
cois Schiele (1), Bruno Kastler (2)
 
(1) CHU Besançon, Cardiologie, Besançon, France - (2) CHU Besançon,
Radiologie, Besançon, France
 
Background:
 
 Microvascular obstruction (MVO) at the acute phase of
myocardial infarction (MI) is associated with greater myocardial damage, left
ventricular (LV) impairment and higher mortality. We aimed to evaluate
whether a correlation exists between plasma levels of cardiac troponin I (cTnI)
at the acute phase of MI and the extent of no-reflow as assessed by 3-T cardiac
magnetic resonance imaging (MRI). Secondly, we aimed to define a cut-off
value for cTnI predictive of no-flow. 
 
Methods:
 
 We included 51 consecutive patients with no previous history of
cardiovascular disease, and presenting for a first MI with or without ST eleva-
tion. Infarct size and extent of no-reflow were evaluated by 3-T MRI during
the acute phase using early and late hyperenhancement imaging at 3 and 15
minutes after injection of gadolinium. Extent of no-reflow at 15 minutes
(MVO) was measured and correlated with repeat doses of cTnI at 6, 12, 24,
48 and 72 hours after admission.
 
Results:
 
 Extent of MVO is significantly correlated to area under the curve
for cTnI (r=0.55, p<0.02), to the area under the ROC curve (p<0.005). After
analysis of ROC curves, a cut-off cTnI value >89 ng/mL at 6 hours seems to
best predict presence of early MVO with a sensitivity of 63% and specificity
of 88.2%.
 
Conclusion:
 
 A cut-off value of 89 ng/mL for cTnI seems to best predict
presence of MVO, which contributes to unfavourable long-term outcome.
Table- Post-CABG troponin and long-term prognosis (abstract 327). 
 Mortality Composite endpoint
Tr-Ic peak HR (95%CI) p HR (95%CI) p
< 5xN ref  ref  
5 to <10 xN 1.02 (0.65-1.61) ns 1.14 (0.84-1.55) ns
10 to <20 xN 1.33 (0.78-2.26) ns 1.45 (1.02-2.07) 0.04
20 xN 1.81 (1.14-2.88) 0.01 1.38 (1.00-1.94) 0.05
Figure- Survival according to post-CABG troponin
